LearnSkin
Course: Modification of Systemic MTSAD Treatment Protocols in the COVID Pandemic Environment and When Considering COVID Vaccination
Modification of Systemic MTSAD Treatment Protocols in the COVID Pandemic Environment and When Considering COVID Vaccination
Vivian Shi, MD

Overview and case discussion of COVID-19 infection and vaccination in patients with moderate-to-severe atopic dermatitis. The potential interference of COVID-19 vaccine immunogenicity for patients on biologics and immunosuppressants will be considered. Considerations for modifications of immunosuppressant dosage surrounding current COVID-19 vaccinations will be discussed.

Learning Objectives

  • Assess the risk of COVID-19 infection and complications in patients with AD
  • Review the mechanism of action and CDC guidelines of currently available COVID-19 vaccines
  • Examine the potential need for systemic medication adjustment when receiving COVID-19 vaccination(s)

Faculty

User: Vivian Shi
Vivian Shi
MD

Dr. Vivian Shi, MD is an Associate Professor of the Department of Dermatology at the University of Arkansas for Medical Sciences (UAMS), where she directs the Eczema Clinic and Hidradenitis Suppurativa Clinic.

Dr. Shi received her undergraduate degree in physiological sciences from UCLA, and
subsequently spent a year performing research on gene regulation in pathogenic bacteria in the department of microbiology at UCLA. She learned her medical degree from the University of Illinois at Chicago. During that time, she also completed a fellowship in the Skin Immunology Laboratory. She was an integral part of the team characterizing the pathophysiology of atopic dermatitis. She then completed her internship in Internal Medicine at the University of Chicago – NorthShore Health System, followed by a dermatology residency at the University of California, Davis, where she also served as chief resident.

Dr. Shi’s research and clinical interests are in complex inflammatory skin conditions (such atopic dermatitis, hidradenitis suppurativa, and psoriasis), skin barrier repair, transepidermal drug delivery, and integrative dermatology. She has served as the principal investigator for numerous industry-sponsored and investigator-initiated clinical and translational studies. She has published over 150 peer-reviewed articles and is the editor for two reference dermatology textbooks on atopic dermatitis and hidradenitis suppurativa. She is on the Board of Directors for the Hidradenitis Suppurativa Foundation, advisory board of the National Eczema Association, and is a member of the International Eczema Council.

View Bio

Related Courses

LearnSkin Logo
All material on this website is protected by copyright. Copyright © LearnHealth Inc. 2024.
This website also contains material copyrighted by 3rd parties.
ABOUT
LEGAL
SUBSCRIBE
To Get Posts Directly In Your Inbox!